FFCP PHASE1:Hg19::chr6:97731019..97731118,-
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p1@MMS22L |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_MMS22L_5end |
Coexpression cluster: | C109_Reticulocytes_non_acute_Hodgkin_Burkitt_retinoblastoma_lymphoma |
Association with transcript: | 0bp_to_ENST00000275053, ENST00000496119, ENST00000508820, ENST00000509383, NM_198468, uc003ppb.2, uc010kcn.1_5end |
EntrezGene: | 253714 |
HGNC: | 21475 |
UniProt: | Q6ZRQ5 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p1@MMS22L |
---|
0
10
20
30
40
50
60
70
80
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 6.63e-49 | 235 |
disease of cellular proliferation | 8.94e-47 | 239 |
cell type cancer | 9.87e-26 | 143 |
organ system cancer | 7.41e-25 | 137 |
hematologic cancer | 3.74e-21 | 51 |
immune system cancer | 3.74e-21 | 51 |
carcinoma | 1.28e-18 | 106 |
leukemia | 1.21e-17 | 39 |
myeloid leukemia | 1.50e-14 | 31 |
disease of anatomical entity | 7.52e-07 | 39 |
Showing 1 to 10 of 10 entries